📰 Tncen News
Page 147 - Tncen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tncen. Real-time updates on events, politics, business and more.
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab, according to a study published online June 12 in JAMA
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- Few athletes can identify sudden cardiac arrest (SCA) or provide cardiopulmonary resuscitation (CPR) to a fallen athlete, according to research presented at the
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- Elevated lipoprotein(a) (Lp[a]) is a predictor of recurrent coronary heart disease (CHD) in older adults, according to a study published online June 12
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- Only one in four U.S. facilities offer buprenorphine for adolescent residential addiction treatment, according to a research letter published in the June 13
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- Early menopause due to hysterectomy is associated with increased risks for a composite of cardiovascular disease (CVD), according to a study published online
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- For patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer, alectinib exposure is lower when taken with low-fat yogurt, according to a
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- After adjustment for body mass index (BMI), clinically important differences in the prevalence of dense breasts persist across racial/ethnic groups, according to a
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- Fido really needs a friend.
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- For outpatients with influenza infection, oseltamivir is not associated with a reduced risk for hospitalization, according to a review published online June 12
June 14, 2023
WEDNESDAY, June 14, 2023 (HealthDay News) -- For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.